Sign In to Request a Protocol
Sign In to Request a Protocol

CJC-1295 DAC (5 mg Vial)

  • Table of Contents

CJC-1295 DAC Research Chart

CJC-1295 DAC has been studied in scientific research related to peptide mechanisms and biological pathways. Research findings may vary depending on study design, methodology, and experimental conditions. This information is provided for research and educational purposes only.

  • Reconstitution: Add 2.0 mL of bacteriostatic water to achieve a concentration of 2.5 mg/mL (2,500 mcg/mL).
  • Research Information: Research studies may evaluate different parameters depending on study design, methodology, and experimental conditions.
  • Measurement Guide: At a concentration of 2.5 mg/mL, 1 unit (0.01 mL) on a U-100 insulin syringe delivers 25 mcg.
  • Storage: Store lyophilized vials at −20 °C (−4 °F). After reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and avoid repeated freeze–thaw cycles.

CJC-1295 DAC is a synthetic peptide studied in scientific research related to growth hormone pathways, receptor interactions, and biological signaling mechanisms. Its DAC modification has been investigated for its role in peptide characteristics and research models.

Research studies have explored CJC-1295 DAC in relation to GHRH-related pathways, cellular communication, and endocrine research models. Findings may vary depending on study design, methodology, and experimental conditions.

Current scientific information is based on ongoing research, including preclinical and limited human studies. Additional research continues to evaluate its biological mechanisms and research applications.

  • Research & Reconstitution Guide

Educational guide for reconstitution and twice-weekly research 

Standard / Gradual Approach (2 mL = 2500 mcg/mL)

WeekDaily Blend (mg)Volume (mL)Weekly Total
Weeks 1–2300 mcg (0.3 mg)12 units (0.12 mL)600 mcg/week
Weeks 3–4500 mcg (0.5 mg)20 units (0.20 mL)1000 mcg/week
Weeks 5–6750 mcg (0.75 mg)30 units (0.30 mL)1500 mcg/week
Weeks 7–121000 mcg (1 mg)40 units (0.40 mL)2000 mcg/week

Research Information: Research methodologies and experimental parameters may vary depending on study design, scientific objectives, and laboratory requirements. Research approaches may differ across scientific investigations and controlled research settings.

Reconstitution Steps

  • Draw 2.0 mL of bacteriostatic water using a sterile syringe.
  • Research Preparation Information: Laboratory preparation methods may vary depending on study design, research requirements, and approved scientific procedures.
  • Gently swirl or roll the vial until the powder has completely dissolved. Do not shake the vial.
  • Label the vial with the reconstitution date and store it refrigerated at 2–8 °C (35.6–46.4 °F), protected from direct light.

Important: This guide is for educational purposes only and is not medical advice. This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

  • Research Information

Plan based on an 8–16 week twice-weekly protocol with gradual titration.

  • Peptide Vials (CJC-1295 DAC, 5 mg each)
  • 8 weeks ≈ 3 vials (~10.2 mg total)
  • 12 weeks ≈ 4 vials (~18.2 mg total)
  • 16 weeks ≈ 6 vials (~26.2 mg total)<br
  • Syringes:
  • Per week: 2 syringes (twice weekly)
  • 8 weeks: 16 syringes
  • 12 weeks: 24 syringes
  • 16 weeks: 32 syringes
  • Bacteriostatic Water (10 mL bottles): Use approximately 2.0 mL per vial for reconstitution.
  • 8 weeks (3 vials): 6 mL → 1 × 10 mL bottle
  • 12 weeks (4 vials): 8 mL → 1 × 10 mL bottle
  • 16 weeks (6 vials): 12 mL → 2 × 10 mL bottles
  • Alcohol Swabs: One for the container top + one for the application area each week
  • Research Information: Research materials and laboratory requirements may vary depending on study design, methodology, and experimental conditions.
  • 8 weeks: 32 swabs → recommend 1 × 100-count box
  • 12 weeks: 48 swabs → recommend 1 × 100-count box
  • 16 weeks: 64 swabs → recommend 1 × 100-count box
  • Protocol Overview

Concise summary of the twice-weekly regimen.

  • Goal: Support sustained GH and IGF-1 elevation for research into GH-axis effects.
  • Research Information: Research studies may evaluate different timeframes and experimental approaches depending on study design, methodology, and laboratory requirements.
  • Research Information: Research studies may evaluate different parameters depending on study design, methodology, and experimental conditions.
  • Reconstitution: 2.0 mL per 5 mg vial (2.5 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
  • Research Protocol

Suggested twice-weekly titration approach.

  • Research Information: Research methodologies and experimental parameters may vary depending on study design, scientific objectives, and laboratory requirements.
  • Research Information: Research studies may evaluate different parameters depending on study design, methodology, and experimental conditions.
  • Frequency: Twice per week (subcutaneous), spaced 3–4 days apart.
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks.
  • Research Information: Research methodologies and experimental approaches may vary depending on study design, scientific objectives, and laboratory requirements.
  • Storage Instructions

Proper storage preserves peptide quality.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); stable for 2–4 weeks; avoid freeze–thaw.
  • Allow vials to reach room temperature before opening to reduce condensation uptake.
  • Important Notes
Practical considerations for consistency and tolerability.
  • Research Information: Laboratory research procedures should follow appropriate scientific standards, safety practices, and approved methodologies.
  • Research Information: Scientific studies may evaluate different methodologies and approaches depending on research objectives, laboratory requirements, and experimental conditions.
  • Research Information: Research findings and observations may vary depending on study design, methodology, and experimental conditions.
  • Research Information: Scientific research may involve documentation and evaluation methods that vary depending on study design, research objectives, and laboratory procedures.
  • Research Information: Research methodologies and laboratory requirements may vary depending on study design, experimental conditions, and approved procedures.
  • How This Works

CJC-1295 DAC has been studied in scientific research related to growth hormone pathways, receptor interactions, and biological signaling mechanisms. Research explores its relationship with GHRH-related processes, cellular communication pathways, and endocrine research models.

Scientific studies continue to evaluate peptide mechanisms, biological responses, and related molecular pathways. Research findings may vary depending on study design, methodology, and experimental conditions.

  • Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

  • Research Information: Research studies have explored peptide interactions with biological pathways and signaling mechanisms. Findings may vary depending on study design, methodology, and experimental conditions.
  • May promote increased lean body mass, reduced fat mass, and improved body composition consistent with GH/IGF-1 axis activation.
  • Enhanced protein synthesis and recovery potential through anabolic signaling.
  • Research Observations: Research findings and observations may vary depending on study design, methodology, and experimental conditions.
  • Some individuals report transient flushing, headache, or water retention during initial titration.
  • Lifestyle Factors

Complementary strategies for best outcomes.

  • Pair with a balanced, protein-forward diet tailored to energy and recovery needs.
  • Combine resistance training and aerobic activity to reinforce GH-mediated adaptations.
  • Prioritize quality sleep (7–9 hours) as endogenous GH release peaks during deep sleep.
  • Manage stress to support hormonal balance and adherence.
  • Scientific Research Information
General subcutaneous guidance from clinical best‑practice resources
  • Clean the vial stopper and skin with alcohol; allow to air dry completely.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
  • Research Information: Scientific research procedures may vary depending on study design, laboratory requirements, and approved methodologies.
  • Hold for 5–10 seconds before withdrawing the needle to ensure complete delivery.
  • Rotate sites systematically (abdomen, thighs, upper arms) each week to avoid lipohypertrophy.
  • Scientific References
We recommend Vitality Labs Peptides for high-purity CJC-1295 DAC (5 mg).

Why Vitality Labs Peptides?

  • High-purity, third-party-tested lots with batch COAs.
  • Consistent, ISO-aligned handling and documentation.
  • Reliable fulfillment to maintain cold-chain integrity.
Contact on Telegram
  • Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

  • References

J Clin Endocrinol Metab (2006)

— Teichman SL et al. Prolonged stimulation of GH and IGF-1 by CJC-1295 in healthy adults.
More Info

J Clin Endocrinol Metab (2006)

— Ionescu M et al. Pulsatile GH secretion persists during continuous CJC-1295 stimulation

More Info

Am J Physiol Endocrinol Metab (2006)

— Alba M et al. Once-daily CJC-1295 normalizes growth in GHRH knockout mouse

More Info

StatPearls (NCBI Bookshelf)

Brinkman JE et al. Physiology, Growth Hormone

More Info

CDC Pink Book (Chapter 6)

— Vaccine administration: subcutaneous route (angle/site; no aspiration)

More Info

Johns Hopkins Arthritis Center

Scientific Research Information on Subcutaneous Methods and Research Practices

More Info

StatPearls (NCBI Bookshelf)

Regular Insulin: subcutaneous administration and site rotation

More Info

Immunize Canada

Scientific Research Reference: Subcutaneous Methods and Research Practices

More Info

Postgrad Med J (2006)

— Ayuk J, Sheppard MC. Growth hormone and its disorders

More Info

Vitality Lab Peptides

— CJC-1295 DAC Research Information and Scientific Background

More Info